Mirum Pharmaceuticals, Inc.
MIRM
$96.55
$3.914.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.75% | 32.03% | 9.41% | -8.31% | -2.10% |
| Total Receivables | 57.54% | 56.33% | 76.79% | 74.28% | 15.18% |
| Inventory | 11.09% | 11.24% | 12.25% | 3.76% | 0.41% |
| Prepaid Expenses | 53.94% | 98.01% | 121.99% | 48.49% | 7.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.94% | 37.23% | 23.26% | 5.48% | 1.35% |
|
|
|||||
| Total Current Assets | 39.94% | 37.23% | 23.26% | 5.48% | 1.35% |
| Net Property, Plant & Equipment | 8.04% | -5.51% | 2.67% | 642.68% | 393.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.44% | -9.34% | -9.13% | -5.28% | -1.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 132.48% | 79.12% | 73.42% | 52.31% | 39.42% |
| Total Assets | 25.65% | 17.55% | 9.85% | 5.87% | 3.73% |
|
|
|||||
| Total Accounts Payable | -34.23% | 27.47% | 79.40% | -27.18% | 97.11% |
| Total Accrued Expenses | 48.76% | 37.10% | 33.31% | 29.28% | 29.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.16% | 35.13% | 94.12% | 359.22% | 54.80% |
| Total Finance Division Other Current Liabilities | 125.38% | 43.54% | 11.91% | 25.53% | 66.00% |
| Total Other Current Liabilities | 125.38% | 43.54% | 11.91% | 25.53% | 66.00% |
| Total Current Liabilities | 62.62% | 38.54% | 28.93% | 20.46% | 45.35% |
|
|
|||||
| Total Current Liabilities | 62.62% | 38.54% | 28.93% | 20.46% | 45.35% |
| Long-Term Debt | 0.56% | 0.55% | 0.55% | 0.55% | 0.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.72% | -13.20% | -4.37% | 2,035.06% | 1,192.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 99.72% | 302.34% | 127.95% | 224.24% | -34.81% |
| Total Liabilities | 18.65% | 13.12% | 9.01% | 9.50% | 11.85% |
|
|
|||||
| Common Stock & APIC | 12.83% | 12.02% | 10.04% | 9.34% | 8.33% |
| Retained Earnings | -3.63% | -6.68% | -9.66% | -13.30% | -15.81% |
| Treasury Stock & Other | 194.10% | -95.98% | 173.79% | -1,884.62% | -122.69% |
| Total Common Equity | 39.47% | 25.87% | 11.43% | -0.57% | -9.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 39.47% | 25.87% | 11.43% | -0.57% | -9.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 39.47% | 25.87% | 11.43% | -0.57% | -9.26% |
|
|
|||||